Skip to main content
. 2020 Jun;9(3):682–692. doi: 10.21037/tlcr-19-477

Figure 3.

Figure 3

Specificity of the model' signature to develop BM. The distribution of probabilities to develop BM provided by the logistic regression model combining clinical and gene expression signatures of 22 genes in patients without metastasis, patients with metastasis in non-brain sites and patients that developed BM. P values for comparison between the groups by Wilcoxon rank-sum test are shown.